Pfizer's Covid Windfall Shrinks, Expands Cost-Cutting Efforts

benzinga.com/general/biotech/25/04/45073128/pfizers-covid-windfall-shrinks-expands-cost-cutting-efforts

Zinger Key Points
- Pfizer Q1 EPS beat at $0.92 vs. $0.67 estimate, but sales dipped 8% YoY to $13.71 billion, below $13.95 billion forecast.
- Paxlovid sales plunged 75%, while Vyndaqel jumped 33% and Comirnaty rose 62% YoY in Q1.
- Don't face extreme market conditions unprepared. Get…

This story appeared on benzinga.com, 2025-04-29 15:31:50.
The Entire Business World on a Single Page. Free to Use →